Global Insulin Glargine Market Size is projected to reach USD 2200 million by 2031, growing at a CAGR of 6.11%: Straits Research New York, United States, March 20, 2024 (GLOBE NEWSWIRE) -- Insulin glargine is a modified, long-acting form of medical insulin used to treat diabetes types I and II. It is subcutaneously injected....

Insulin Drugs Global Market Research Report 2023 Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Insulin Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global insulin drugs market will grow from...